Brendan Borrell is a freelance journalist based in Los Angeles, California. His stories have appeared in The Atlantic, The New York Times, Bloomberg Businessweek, Outside, National Geographic and many other publications. He is the author of “The First Shots: The Epic Rivalries and Heroic Science Behind the Race to the Coronavirus Vaccine,” and he has a Ph.D. in integrative biology from the University of California, Berkeley.
Brendan Borrell
Contributing writer
From this contributor
Exclusive: Who is Richard Frye, the neurologist who researches and advocates for leucovorin as an autism treatment?
Frye has led two placebo-controlled trials of the folate supplement in autistic people; the first was suspended by regulators, and the other has yet to be published.
Alzheimer’s scientist forced to retract paper during his own replication effort
Gary Dunbar, a neuroscientist at Central Michigan University, was attempting to redo the 2020 paper after a collaborator admitted to using flawed data in the original work.
Alzheimer’s scientist forced to retract paper during his own replication effort
By
Brendan Borrell
18 July 2025 | 4 min read
Former Columbia University psychiatrist committed research misconduct, says federal watchdog
Bret Rutherford, whose research was halted following a suicide in a clinical trial, falsely reported participant eligibility, according to the U.S. Office of Research Integrity.
Former Columbia University psychiatrist committed research misconduct, says federal watchdog
By
Brendan Borrell, Ellie Kincaid
8 October 2024 | 3 min read
FDA describes ‘objectionable conditions’ at New York State Psychiatric Institute
The facility’s institutional review board failed to report a 2021 incident and “serious and ongoing noncompliance” by a principal investigator, according to a letter released by the federal agency this week.
FDA describes ‘objectionable conditions’ at New York State Psychiatric Institute
By
Brendan Borrell
2 April 2024 | 6 min read
Controversial dyslexia study marred by methodological and ethical problems, researchers say
Subsequent studies have also failed to validate a range of products based on the work.
Controversial dyslexia study marred by methodological and ethical problems, researchers say
By
Brendan Borrell
27 February 2024 | 8 min read
Explore more from The Transmitter
Michael Shadlen explains how theory of mind ushers nonconscious thoughts into consciousness
All of our thoughts, mostly nonconscious, are interrogations of the world, Shadlen says. The opportunity to report our answers to ourselves or others brings a thought into conscious awareness.
Michael Shadlen explains how theory of mind ushers nonconscious thoughts into consciousness
All of our thoughts, mostly nonconscious, are interrogations of the world, Shadlen says. The opportunity to report our answers to ourselves or others brings a thought into conscious awareness.
By
Paul Middlebrooks
28 January 2026 | 1 min read
‘Peer review is our strength’: Q&A with Walter Koroshetz, former NINDS director
In his first week off the job, the former National Institute of Neurological Disorders and Stroke director urges U.S. scientists to remain optimistic about the future of neuroscience research, even if the executive branch “may not value what we do.”
‘Peer review is our strength’: Q&A with Walter Koroshetz, former NINDS director
In his first week off the job, the former National Institute of Neurological Disorders and Stroke director urges U.S. scientists to remain optimistic about the future of neuroscience research, even if the executive branch “may not value what we do.”
By
Angie Voyles Askham
27 January 2026 | 7 min read
Viral remnant in chimpanzees silences brain gene humans still use
The retroviral insert appears to inadvertently switch off a gene involved in brain development.
Viral remnant in chimpanzees silences brain gene humans still use
The retroviral insert appears to inadvertently switch off a gene involved in brain development.
By
Siddhant Pusdekar
27 January 2026 | 5 min read